Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Loss-of-function mutations in parkin are the predominant cause of familial Parkinson's disease. We previously reported that parkin-/- mice exhibit nigrostriatal deficits in the absence of nigral degeneration. Parkin has been shown to function as an E3 ubiquitin ligase. Loss of parkin function, therefore, has been hypothesized to cause nigral degeneration via an aberrant accumulation of its substrates. Here we employed a proteomic approach to determine whether loss of parkin function results in alterations in abundance and/or modification of proteins in the ventral midbrain of parkin-/- mice. Two-dimensional gel electrophoresis followed by mass spectrometry revealed decreased abundance of a number of proteins involved in mitochondrial function or oxidative stress. Consistent with reductions in several subunits of complexes I and IV, functional assays showed reductions in respiratory capacity of striatal mitochondria isolated from parkin-/- mice. Electron microscopic analysis revealed no gross morphological abnormalities in striatal mitochondria of parkin-/- mice. In addition, parkin-/- mice showed a delayed rate of weight gain, suggesting broader metabolic abnormalities. Accompanying these deficits in mitochondrial function, parkin-/- mice also exhibited decreased levels of proteins involved in protection from oxidative stress. Consistent with these findings, parkin-/- mice showed decreased serum antioxidant capacity and increased protein and lipid peroxidation. The combination of proteomic, genetic, and physiological analyses reveal an essential role for parkin in the regulation of mitochondrial function and provide the first direct evidence of mitochondrial dysfunction and oxidative damage in the absence of nigral degeneration in a genetic mouse model of Parkinson's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, mitophagy deficiency favored by ablation of Prkn (Palacino et al, 2004; Pickrell et al, 2015) or Pink1 (Gautier et al, 2008) sensitizes mice to oxidative stress, while worsening neural damage when combined with mitochondrial dysfunction (mitochondrial DNA [mtDNA] mutator‐prkn/parkin‐KO mice) (Pickrell et al, 2015).”
From Autophagy in major human diseases (2021) · cites this paper as Palacino et al, 2004
In the citing paper
“Both Pink1 and Parkin knockout mice exhibit increased ROS levels and mitochondrial dysfunction (43, 44), and persistent increased ROS is one of the important factors in accelerating cellular senescence (42, 45).”
From Impaired mitophagy leads to cigarette smoke stress‐induced cellular senescence: implications for chronic obstructive pulmonary disease (2015) · cites this paper as [43]
Citations
Cites
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE
Olanow, C. W., & Tatton, W. G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.123 · Cited by 1,396
Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants
Greene, J. C., Whitworth, A. J., Kuo, I., Andrews, L. A., Feany, M. B., & Pallanck, L. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737556100 · Cited by 1,203
Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease.
Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtman, E. R., & Mizuno, Y. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2696 · Cited by 981
Research works printed but not linked: 5
- Jenner, 1996, Neurology, 47, 5161
- Koller, 1986, Neurology, 36
- Darios, 2003, Hum. Mol. Genet., 12, 517, 10.1093/hmg/ddg044 · doi:10.1093/hmg/ddg044 · Paper page
- Klose, 1999, Methods Mol. Biol., 112, 67
- Dubin, 1989, Mol. Cell. Biol., 9, 1083
Cited by
Items 801–900 of 1,000
Dysfunction in parkin aggravates inflammatory bone erosion by reinforcing osteoclast activity
Kim, E. Y., Kim, J.-E., Kim, Y.-E., Choi, B., Sohn, D. H., Park, S.-O., Chung, Y., Kim, Y., Robinson, W. H., Kim, Y., et al. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-00973-0 · Cited by 5
Engrailed 1 deficiency induces changes in ciliogenesis during human neuronal differentiation
Hembach, S., Schmidt, S. W., Orschmann, T., Burtscher, I., Lickert, H., Giesert, F., Weisenhorn, D. M. V., & Wurst, W. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106474 · Cited by 5
Effects of redox interference on the pancreatic mitochondria and the abnormal blood glucose
Xie, F., Wu, M., Lai, B., Halim, M., Liu, S., & Shi, D. (2021) · Free Radical Research · doi:10.1080/10715762.2020.1866180 · Cited by 5
Fluorescent Parkin Cell-Based Assay Development for the Screening of Drugs against Parkinson Disease
Villacé, P., Mella, R. M., Roura‐Ferrer, M., Valcárcel, M., Salado, C., Castilla, A., & Kortázar, D. (2016) · SLAS DISCOVERY · doi:10.1177/1087057116671498 · Cited by 5
Proteomics; applications in familial Parkinson's disease
Li, Y., & Cookson, M. R. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14708 · Cited by 5
Identification and characterization of a novel endogenous murine parkin mutation
Ramsey, C. P., & Giasson, B. I. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06605.x · Cited by 5
Wang, H., Chen, R., Xiao, L., Kumar, M., Acevedo-Cintrón, J. A., Siuda, J. S., Koziorowski, D., Wszołek, Z. K., Dawson, V. L., & Dawson, T. M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.23.546087 · Cited by 5
Zanon, A., Kalvakuri, S., Raković, A., Foco, L., Guida, M., Schwienbacher, C., Serafin, A., Rudolph, F., Trilck, M., Grünewald, A., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy408 · Cited by 5
7 Some practices and pitfalls of sample preparation for isoelectric focusing in proteomics
Herbert, B. R. (2005) · Separation science and technology · doi:10.1016/s0149-6395(05)80010-8 · Cited by 5
Darvish-Damavandi, M., Chan, E. C. Y., Kraus, J. P., Ho, P. C., & Kang, T. S. (2014) · Bioanalysis · doi:10.4155/bio.13.297 · Cited by 5
Autophagy, the “Master” Regulator of Cellular Quality Control: What Happens when Autophagy Fails?
Raquel, A., Catarina, R. A., & Morais, S. (2013) · InTech eBooks · doi:10.5772/55196 · Cited by 4
Rahman, M. M., Sarker, M. T., Ahmed, S., Uddin, M. N., Islam, M. S., Islam, M. R., Das, S., Mukherjee, N., Hemeg, H. A., Rauf, A., et al. (2023) · Process Biochemistry · doi:10.1016/j.procbio.2023.07.007 · Cited by 4
Lin, W., & Kang, U. J. (2005) · Journal of Clinical Neurology · doi:10.3988/jcn.2005.1.2.107 · Cited by 4
Berg, D. (2007) · Elsevier eBooks · doi:10.1016/b978-044452809-4/50148-4 · Cited by 4
The Role of Structural Variants in the Genetic Architecture of Parkinson’s Disease
Miano‐Burkhardt, A., Jerez, P. Á., Daida, K., Bandrés‐Ciga, S., & Billingsley, K. J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094801 · Cited by 4
Goldman, C., Kareva, T., Sarrafha, L., Schuldt, B. R., Sahasrabudhe, A., Ahfeldt, T., & Blanchard, J. (2025) · iScience · doi:10.1016/j.isci.2025.112816 · Cited by 4
Keleş, B. S., Rumman, B., Samarie, M. A. J. A., Özdemir, Y., Çakmak, Ö. Ö., Akyoldaş, G., Ertan, S., & Sokullu, E. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02461-z · Cited by 4
Drosophila Models of Parkinson Disease
Pallanck, L. J., & Whitworth, A. J. (2005) · Elsevier eBooks · doi:10.1016/b978-012088382-0/50014-1 · Cited by 4
Non‐human primate models of Parkinson's disease: Decoding pathogenesis and advancing therapies
Zhang, S., Yuan, L., Wu, Z., Du, X., Kubiak, J. Z., Yue, F., Yan, X., Jiang, G., & Huang, Y. (2025) · Brain‐X · doi:10.1002/brx2.70032 · Cited by 4
Proteome changes in autosomal recessive primary microcephaly
Zaqout, S., Mannaa, A. M., Klein, O., Krajewski, A., Klose, J., Luise‐Becker, L., Elsabagh, A. A., Ferih, K., Kraemer, N., Ravindran, E., et al. (2022) · Annals of Human Genetics · doi:10.1111/ahg.12489 · Cited by 4
Self-citationThe pathological role of Pael-receptor/GPR37 in AR-JP
Takahahshi, R. (2006) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2006.05.013 · Cited by 4
Die Parkinson‐Krankheit: Molekulare Mechanismen und Genetik
Büeler, H. (2006) · Pharmazie in unserer Zeit · doi:10.1002/pauz.200600167 · Cited by 4
Zanon, A., Guida, M., Lavdas, A. Α., Corti, C., Rueda, M. P. C., Negro, A., Pramstaller, P. P., Domingues, F. S., Hicks, A. A., & Pichler, I. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-04850-3 · Cited by 4
Stefanoni, G., Sala, G., Tremolizzo, L., Brighina, L., & Ferrarese, C. (2011) · InTech eBooks · doi:10.5772/17030 · Cited by 4
Interplay between Alpha-Synuclein and Oxidative Stress in Parkinson´s Disease Cell Models
Perfeito, R. (2012) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 4
The Importance of Olfactory and Motor Endpoints for Zebrafish Models of Neurodegenerative Disease
Shamchuk, A. L., & Tierney, K. B. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415894-8.00027-0 · Cited by 3
The Importance of Olfactory and Motor Endpoints for Zebrafish Models of Neurodegenerative Disease
Shamchuk, A. L., Allison, W. T., & Tierney, K. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809468-6.00021-8 · Cited by 3
Aerts, L., & Morais, V. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803783-6.00002-x · Cited by 3
Neurodegeneration caused by ER stress?
Takahashi, R. (2004) · Folia Pharmacologica Japonica · doi:10.1254/fpj.124.375 · Cited by 3
Genes involved in the development of Parkinson
Teixeira, D., & Cardoso, I. (2017) · Open Journal of Parkinson s Disease and Treatment · doi:10.17352/ojpdt.000005 · Cited by 3
Genetics of Parkinson's Disease
Sinha, K. (2005) · Jaypee Brothers Medical Publishers (P) Ltd. eBooks · doi:10.5005/jp/books/10587_5 · Cited by 3
Oxidative Modifications of Parkin Underlie its Selective Neuroprotection in Adult Human BrainPreprint
Tokarew, J. M., Kodsi, D. N. E., Lengacher, N. A., Fehr, T. K., Nguyen, A., O’Nuallain, B., Jin, M., Khan, J. M., Ng, A. C., Li, J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.19.953034 · Cited by 3
Zhang, Z., Xu, B., Lv, T., Shi, Y., Wang, M., Hu, D., Hu, A., Li, P., Lin, S., Zhang, S., et al. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300056 · Cited by 3
Rodent Models of Autosomal Recessive Parkinson Disease
Gispert, S., Auburger, G. W. J., Kuruvilla, K. P., & LeDoux, M. S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405195-9.00019-6 · Cited by 3
Santiago-Lopez, A. J., Hovell, C. M., Lee, H., & Kim, Y. (2015) · Biosystems & biorobotics · doi:10.1007/978-3-319-21813-7_13 · Cited by 3
EXPERIMENTAL ANIMAL MODELS OF PARKINSON’S DISEASE: AN OVERVIEW
Imran, M., Mishra, A., Usmani, A., & Eqbal, A. (2020) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2020.v13i11.39131 · Cited by 3
Cell Therapy for Parkinson’s Disease
Chen, Z. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811353-0.00049-x · Cited by 3
Un peu de Rose dans la maladie de Parkinson
Berthier, A. (2008) · médecine/sciences · doi:10.1051/medsci/2008242118 · Cited by 3
Genetics of Parkinson's Disease—An Overview
Klein, C. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00002-7 · Cited by 3
The PINK1/Parkin pathway of mitophagy exerts a protective effect during prion disease
Ward, A. E., Jessop, F., Faris, R., Hollister, J. R., Shoup, D. W., Race, B., Bosio, C. M., & Priola, S. A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0298095 · Cited by 3
An Overview of the Genetics of Parkinson's Disease
Aimrane, A., Sabir, E., Laadraoui, J., El‐Mansoury, B., Smimih, K., Khanouchi, M., Amine, S. E., Lafhal, K., Oublal, K., Baz, S. E., et al. (2023) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-6684-5156-4.ch010 · Cited by 3
Nugent, S. (2008) · Arrow - TU Dublin (Technological University Dublin) · doi:10.21427/d7wg6c · Cited by 3
Phosphorylation Events in Selective Mitophagy: Possible Biochemical Markers?
Zhang, W., Wu, H., Liu, L., Zhu, Y., & Chen, Q. (2013) · Current Pathobiology Reports · doi:10.1007/s40139-013-0033-8 · Cited by 2
Loss of PINK1 or Parkin Function Results in a Progressive Loss of Mitochondrial Function
Taanman, J., & Protasoni, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-812146-7.00007-x · Cited by 2
Tetrahydroisoquinoline Neurotoxins in Parkinson Disease
DeCuypere, M. G. (2010) · doi:10.21007/etd.cghs.2010.0067 · Cited by 2
Rego, A. C., Cardoso, S. M., & Oliveira, C. R. (2007) · Springer eBooks · doi:10.1007/978-0-387-70830-0_9 · Cited by 2
Yamashita, S.-I., & Kanki, T. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-981-97-4584-5_16 · Cited by 2
Reactive oxygen and nitrogen species: Weapons of neuronal destruction
Mazzulli, J., Lind, S., & Ischiropoulos, H. (2005) · Cited by 2
Norazit, A., Mellick, G. D., & Meedeniy, A. C. B. (2012) · InTech eBooks · doi:10.5772/33459 · Cited by 2
Oxidative Stress, Redox Homeostasis and NF-κB Signaling in Neurodegeneration
Anandhan, A., Hernández-Franco, P., & Franco, R. (2015) · ACS symposium series · doi:10.1021/bk-2015-1200.ch003 · Cited by 2
Current Concepts on the Etiology and Pathogenesis of Parkinson Disease
Fahn, S., Jankovic, J. J., Hallett, M., & Jenner, P. G. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-07941-2.50008-5 · Cited by 2
Ameer, J. M., Alexander, S. M., Navya, K., Shenoi, R. A., & Chandra, G. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117935 · Cited by 2
Genetics Of Parkinson’s Disease
Sriram, S. R., Dawson, T. M., & Dawson, V. L. (2005) · Neurological disease and therapy · doi:10.1201/9780849358364.ch24 · Cited by 2
Parkin and Parkinson’s Disease
Tay, S.-P., Grace, G. Y., Calvin, W. S., & Lim, K. (2011) · InTech eBooks · doi:10.5772/16990 · Cited by 2
Exocytosis, Mitochondrial Injury and Oxidative Stress in Neurodegenerative Diseases
Zanin, M., & Keating, D. J. (2009) · Contemporary clinical neuroscience · doi:10.1007/978-1-60327-342-8_4 · Cited by 2
Mitochondrial Biology in Parkinson's Disease
Lee, Y. (2009) · Interdisciplinary Bio Central · doi:10.4051/ibce.2009.2.0011 · Cited by 2
Natural Products as Potential Therapeutic Strategies for Parkinson's Disease
Cha, H.-R., Lee, M., & Cho, H. (2023) · Journal of Experimental & Biomedical Sciences/Biomedical Science Letters · doi:10.15616/bsl.2023.29.3.121 · Cited by 2
Midbrain on Fire: mtDNA Ignites Neuroinflammation in PRKN‐P
Narendra, D. P., & Thayer, J. A. (2022) · Movement Disorders · doi:10.1002/mds.29073 · Cited by 2
Biomarker Discovery with Mass Spectrometry Imaging and Profiling
Dunham, S. J. B., Neumann, E. K., Lanni, E. J., Ong, T., & Sweedler, J. V. (2019) · Wiley eBooks · doi:10.1002/9781119081661.ch4 · Cited by 2
Fournier, I., Franck, J., Mériaux, C., & Salzet, M. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-7197-5_21 · Cited by 2
Nakai, A., Fukushima, Y., Yamamoto, A., Amatsu, Y., Chen, X., Nishigori, M., Yoshioka, Y., Kaneko, M., Koshiba, T., & Watanabe, T. (2024) · FEBS Letters · doi:10.1002/1873-3468.14876 · Cited by 2
Role of Mitochondrial Fission and Mitophagy in Parkinson’s Disease
Galindo, M. F., Solesio, M. E., & Jordán, J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405528-5.00014-6 · Cited by 2
Maulik, M. (2018) · ScholarWorks - UA (University of Alaska System) · Cited by 2
The analysis of parkin in Drosophila melanogaster
Haywood, A. F. M. (2006) · Memorial University Research Repository (Memorial University) · Cited by 2
Functions of GDNF/Ret signaling in models of autosomal recessive Parkinson’s disease
Klein, P. (2011) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.16690 · Cited by 2
Aslanzadeh, V., Glendinning, S., Sari, Y., Clarke, M., Rodger, C. J., Lin, X., Lenka, D. R., Richardson, L., Liang, J. R., Kleinz, T., et al. (2026) · doi:10.64898/2026.02.09.704817 · Cited by 1
“…of recombinant Parkin that enable direct measurement of catalytic activity based on autoubiquitylation or substrate-based ubiquitylation [23, 24] ; human cell based assays of Parkin ubiquitylation, pSer65-Ub, and mitophagy [25, 26, 42] as well as in vivo models in Drosophila and mice [42, 48, 49].”
Golden, T. R., Morten, K., Johnson, F., Samper, E., & Melov, S. (2005) · Elsevier eBooks · doi:10.1016/b978-012088387-5/50008-x · Cited by 1
Bureau, S. C. (2022) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2022-14889 · Cited by 1
Romdhan, S. B. (2019) · theses.fr (ABES) · doi:10.70675/6735d8bdz3448z4836z8b6dzffcd8f2bd2da · Cited by 1
Understanding and treating neurodegeneration: insights from the flies
Lu, B. (2005) · AGE · doi:10.1007/s11357-005-2917-y · Cited by 1
The Environmental Contribution to Redox Dyshomeostasis in Parkinson’s Disease
Garza-Lombó, C., & Franco, R. (2022) · Molecular and integrative toxicology · doi:10.1007/978-3-030-87451-3_4 · Cited by 1
Mitochondrial Dysfunction and Protein Aggregation in the Cybrid Cell Model of Parkinson's Disease
Cronin-Furman, E. N. (2013) · doi:10.18130/v3dz3t · Cited by 1
Aging and Parkinson’s Disease: Pathological Insight on Model Mice
Sato, S., & Hattori, N. (2022) · Springer eBooks · doi:10.1007/978-981-16-7977-3_23 · Cited by 1
Crichton, R. R., & Ward, R. J. (2013) · Wiley eBooks · doi:10.1002/9781118553480.ch06 · Cited by 1
Cellular and Molecular Mechanisms Contributing to Parkinson’s Disease
Madhuranthagan, M., Benito Johnson., D., Essly Selva Jasmine., P., Suresh., R., & Senthil Kumar., C. (2026) · Research Journal of Pharmacology and Pharmacodynamics · doi:10.52711/2321-5836.2026.00005 · Cited by 1
Dysfunctional Ubiquitin-Proteasome System and Consequences: Disease Mechanism
Milmile, M., Singh, S., Pandey, A., Ahire, N., & Chawla, R. (2026) · Springer eBooks · doi:10.1007/978-981-95-6099-8_2 · Cited by 1
Mitochondrial DNA in neurons and its modulation by neurotoxins
Santos, M. S. (2006) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Sultana, R., Poon, H. F., & Butterfield, D. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-72076-0_15 · Cited by 1
Autophagy in Aging and Longevity
Nakamura, S., Shioda, T., & Yoshimori, T. (2022) · Springer eBooks · doi:10.1007/978-981-16-7977-3_11 · Cited by 1
Role of Mitochondria and Oxidative Stress in Parkinson’s Disease
Santos, R. X., Correia, S. C., Cardoso, S., Carvalho, C., Candeias, E., Plácido, A. I., Duarte, A. I., Santos, M. S., & Moreira, P. I. (2014) · CRC Press eBooks · doi:10.1201/b16653-26 · Cited by 1
Parkinson Disease: Molecular Insights
Savitt, J. M., Dawson, V. L., & Dawson, T. M. (2007) · Elsevier eBooks · doi:10.1016/b978-012369509-3.50017-2 · Cited by 1
An Overview of Target Specific Neuro-Protective and Neuro-Restorative Strategies
Al, A., Al, K., Al-, A., Arshaduddin, M., & Tariq, M. (2012) · InTech eBooks · doi:10.5772/34731 · Cited by 1
Yan, Y., & Jiao, R. (2015) · Wiley eBooks · doi:10.1002/9781119017127.ch6 · Cited by 1
Parkin modulates gene expression in control and ceramide-treated PC12 cells
Unschuld, P. G., Dächsel, J. C., Darios, F. D., Kohlmann, A., Casademunt, E., Lehmann‐Horn, K., Dichgans, M., Ruberg, M., Brice, A., Gasser, T., et al. (2006) · Aktuelle Neurologie · doi:10.1055/s-2006-953145 · Cited by 1
Hatano, T., & Hattori, N. (2011) · Wiley eBooks · doi:10.1002/9780470015902.a0006026.pub2 · Cited by 1
Karami, M. (2019) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York) · Cited by 1
Cronin, A. (2018) · Arrow@dit (Dublin Institute of Technology) · doi:10.13025/17676 · Cited by 1
Lead Phytomolecules for Treating Parkinson’s Disease
Agrawal, K. K., Veer, C., Murti, Y., & Singh, S. P. (2024) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/0118715249355503241210101001 · Cited by 1
Correction: A Systematic Proteomic Study of Irradiated DNA Repair Deficient Nbn-Mice
Melchers, A., Stöckl, L., Radszewski, J., Anders, M., Krenzlin, H., Kalischke, C., Scholz, R., Jordan, A., Nebrich, G., Klose, J., et al. (2009) · PLoS ONE · doi:10.1371/annotation/06306df9-1db3-4e7b-a7ce-18338b655967 · Cited by 1
Self-citationModeling of Parkinson's Disease in Different Models
Subhan, I., & Siddique, Y. H. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273326866240922193029 · Cited by 1
Spector, E., Michaeli, L., Nitzan, A., Grobe, H., Axel, G., Abu‐Shach, U. B., Zinger, H., Carvalho, C. A., Zaidel‐Bar, R., & Broday, L. (2025) · The FASEB Journal · doi:10.1096/fj.202402785rrr · Cited by 1
The Role of Parkin-Mediated Mitophagy During Aging and Exercise in Skeletal Muscle
Chen, C. C. W. (2018) · YorkSpace (York University) · Cited by 1
Wang, S.-H., Knudson, C. M., Cullen, J. J., Goel, A., Janz, S., & Spitz, D. R. (2012) · doi:10.17077/etd.bbjshj2n · Cited by 1
Rawi, S. A., Tyers, P., Barker, R. A., & Laman, H. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02294-y · Cited by 1
Doença de Parkinson: genética e farmacogenómica
Damásio, M. P. C. (2020) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
Chen, O., Hui, K. K., Raudzus, F., & Henderson, J. T. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-09066-5 · Cited by 1
Effects of Parkin and mutant Huntingtin on the NF-kB signaling pathway
Patra, M. (2015) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.19974 · Cited by 1
Darabi, S., Noori-Zadeh, A., Rajaei, F., Abbaszadeh, H., Abdollahifar, M., & Bakhtiyari, S. (2019) · Neurophysiology · doi:10.1007/s11062-019-09798-5 · Cited by 1
The Role of Parkin and Mitophagy in Acetaminophen and Alcohol-induced Liver Injuries
Williams, J. (2015) · KU ScholarWorks (The University of Kansas) · Cited by 1
Caenorhabditis elegans as an Experimental Model Organism to Study Parkinson's Disease-Related Genes
Springer, W. (2005) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.4027 · Cited by 1
Metadata
- Authors
- Palacino, J. J., Sagi, D., Goldberg, M. S., Krauss, S., Motz, C., Wacker, M., Klose, J., & Shen, J.
- Affiliations
- Brigham and Women's Hospital (US)
- Beth Israel Deaconess Medical Center (US)
- Charité – Universitätsmedizin Berlin (DE)
- Corresponding author
- Shen, Jie
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-04
- Volume
- 279
- Issue
- 18
- Pages
- 18614-18622
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2140647923
- Cited by
- 995
- References
- 66
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 34 · 2023: 29 · 2022: 27 · 2021: 44 · 2020: 51 · 2019: 39 · 2018: 41 · 2017: 32 · 2016: 41 · 2015: 41 · 2014: 42 · 2013: 60 · 2012: 49
- FWCI
- 42.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6031 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Keywords
- Parkin, Parkinson's disease, mitochondrial dysfunction, oxidative stress, E3 ubiquitin ligase, nigrostriatal pathway, complex I, cytochrome c oxidase, respiratory capacity, lipid peroxidation, protein peroxidation, serum antioxidant capacity, metabolic abnormalities
- MeSH terms
- Animals, Antioxidants, Basal Ganglia, Mitochondria, Oxidative Phosphorylation, Parkinson Disease, Protein Processing, Post-Translational, Weight Gain, Reactive Oxygen Species, Mice, Knockout, Oxidative Stress, Cell Respiration, Mitochondrial Proteins, Mitochondrial Diseases, Ubiquitin-Protein Ligases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.